TY - JOUR
T1 - Risk of lymphoid malignancy associated with cancer predisposition genes
AU - Regeneron Genetics Center
AU - Research Program Management & Strategic Initiatives
AU - Therapeutic Area Genetics
AU - Analytical Genomics and Data Science
AU - Genome Informatics
AU - Clinical Informatics
AU - Sequencing and Lab Operations
AU - RGC Management and Leadership Team
AU - Boddicker, Nicholas J.
AU - Mwangi, Raphael
AU - Robinson, Dennis P.
AU - Allmer, Cristine
AU - Rosenthal, Allison C.
AU - Habermann, Thomas M.
AU - Feldman, Andrew L.
AU - Rimsza, Lisa M.
AU - King, Rebecca L.
AU - Larson, Melissa C.
AU - Negaard, Bri J.
AU - Norman, Aaron D.
AU - Rajkumar, Nikhil
AU - Ansell, Stephen M.
AU - Dispenzieri, Angela
AU - Murray, David L.
AU - Rajkumar, Vincent
AU - Kumar, Shaji
AU - Abeykoon, Jithma P.
AU - Hernandez, Jaimee
AU - Rana, Nadia
AU - Nishtala, Nirupama
AU - Mitnaul, Lyndon J.
AU - Mighty, Jason
AU - LeBlanc, Michelle G.
AU - Jones, Marcus B.
AU - Chen, Esteban
AU - Rodriguez-Flores, Juan
AU - Tzoneva, Gannie
AU - Rajagopal, Veera
AU - De, Tanima
AU - Gokhale, Sujit
AU - Gelfman, Sahar
AU - Nakka, Priyanka
AU - Akbari, Parsa
AU - Sosina, Olukayode
AU - Verweij, Niek
AU - Riaz, Moeen
AU - Haas, Mary
AU - Kapoor, Manav
AU - Praveen, Kavita
AU - Bovijn, Jonas
AU - Jan Freudenberg, Freudenberg
AU - Hindy, George
AU - Nowakowski, Grzegorz S.
AU - Witzig, Thomas E.
AU - Novak, Anne J.
AU - Slager, Susan L.
AU - Vachon, Celine M.
AU - Cerhan, James R.
N1 - Publisher Copyright:
© The Author(s) 2025.
PY - 2025/12
Y1 - 2025/12
N2 - We investigated the prevalence of rare inherited pathogenic variants (PV) in 19 cancer predisposition genes regularly included on multi-gene panel testing based on NCCN guidelines and their association with the risk of lymphoid malignancies (LM) overall and by common lymphoma subtypes and multiple myeloma. The study population included newly diagnosed LM cases (N = 6990) and unrelated controls (N = 42,632), excluding individuals with a history of hematologic malignancy. Whole exome sequencing was performed on DNA from whole blood. PV were defined as loss-of-function (i.e., nonsense, frameshift, consensus splice sites) or identified as “pathogenic” or “likely pathogenic” in the ClinVar database. A total of 1816 (3.7%) individuals had a PV across the 19 genes, higher in cases (4.7%) than controls (3.5%). In controls, CHEK2 (1.0%), ATM (0.4%), BRCA2 (0.4%), and BRCA1 (0.3%) had the highest prevalence. ATM (odds ratio [OR] = 1.86, 95% confidence interval [CI]: 1.36–2.49), CHEK2 (OR = 1.74, 95% CI: 1.42–2.13) and TP53 (OR = 9.07, 95% CI: 4.51–18.87) were associated with increased risk of LM overall and were further validated in the UK Biobank. We observed heterogeneity in associations by LM subtype. These results demonstrate that several commonly tested cancer predisposition genes are associated with an increased risk of LM.
AB - We investigated the prevalence of rare inherited pathogenic variants (PV) in 19 cancer predisposition genes regularly included on multi-gene panel testing based on NCCN guidelines and their association with the risk of lymphoid malignancies (LM) overall and by common lymphoma subtypes and multiple myeloma. The study population included newly diagnosed LM cases (N = 6990) and unrelated controls (N = 42,632), excluding individuals with a history of hematologic malignancy. Whole exome sequencing was performed on DNA from whole blood. PV were defined as loss-of-function (i.e., nonsense, frameshift, consensus splice sites) or identified as “pathogenic” or “likely pathogenic” in the ClinVar database. A total of 1816 (3.7%) individuals had a PV across the 19 genes, higher in cases (4.7%) than controls (3.5%). In controls, CHEK2 (1.0%), ATM (0.4%), BRCA2 (0.4%), and BRCA1 (0.3%) had the highest prevalence. ATM (odds ratio [OR] = 1.86, 95% confidence interval [CI]: 1.36–2.49), CHEK2 (OR = 1.74, 95% CI: 1.42–2.13) and TP53 (OR = 9.07, 95% CI: 4.51–18.87) were associated with increased risk of LM overall and were further validated in the UK Biobank. We observed heterogeneity in associations by LM subtype. These results demonstrate that several commonly tested cancer predisposition genes are associated with an increased risk of LM.
UR - https://www.scopus.com/pages/publications/105003430240
UR - https://www.scopus.com/pages/publications/105003430240#tab=citedBy
U2 - 10.1038/s41408-025-01283-z
DO - 10.1038/s41408-025-01283-z
M3 - Article
C2 - 40253392
AN - SCOPUS:105003430240
SN - 2044-5385
VL - 15
JO - Blood cancer journal
JF - Blood cancer journal
IS - 1
M1 - 71
ER -